Wednesday, December 30, 2020

Glenmark Pharma gets USFDA nod for erectile dysfunction treatment drug

Glenmark Pharma gets USFDA nod for erectile dysfunction treatment drug Glenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets USP in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3hzEsrl
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Short-term volatility may persist, but FII flows and economic activity to keep sentiment positive: Vikas Khemani

Vikas Khemani of Carnelian Asset Management remains optimistic about Indian markets, citing a strong domestic growth story and the resolutio...